TCM
RYTM icon

TimesSquare Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

TimesSquare Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-556,290
Closed -$12.2M – 226
2019
Q2 		$12.2M Sell
556,290
-183,760
-25% -$4.64M 0.09% 197
2019
Q1 		$20.3M Sell
740,050
-14,766
-2% -$424K 0.16% 172
2018
Q4 		$20.3M Buy
754,816
+91,231
+14% +$2.52M 0.18% 172
2018
Q3 		$19.4M Buy
663,585
+75,300
+13% +$2.38M 0.13% 199
2018
Q2 		$18.4M Buy
+588,285
New +$16.1M 0.12% 206

Other funds holding RYTM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TimesSquare Capital Management's RYTM Position: Q3 2019 in Review

TimesSquare Capital Management sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2019, closing a stake of 556,290 shares — an estimated $12.2M sold.

TimesSquare Capital Management first reported a position in RYTM in Q2 2018 and held it in 5 quarters. The position peaked at $20.3M in Q4 2018. 84 funds tracked by Wall St. Rank hold RYTM as of Q3 2019.

  • TimesSquare Capital Management reported no remaining Rhythm Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • TimesSquare Capital Management sold 556,290 Rhythm Pharmaceuticals shares in Q3 2019, an estimated $12.2M.
  • TimesSquare Capital Management first reported a position in Rhythm Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • TimesSquare Capital Management's Rhythm Pharmaceuticals position peaked at $20.3M in Q4 2018.
  • 84 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2019.

Based on TimesSquare Capital Management's 13F filing for Q3 2019, filed 5 Nov 2019.